Historical Perspective for Understanding of Adrenergic Receptors

Current Topics in Membranes

Volumn 67, Issue , 2011, Pages 1-17

  Limbird, Lee E ^a  

^a FISK UNIVERSITY   (United States)

Author keywords

Adrenergic; Antagonist; Arrestin; Receptor; Scaffolding; Selectivity

Indexed keywords

ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL; BOOK; DRUG EFFECT; ENDOCYTOSIS; HISTORY; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ANIMALS; ENDOCYTOSIS; HISTORY, 20TH CENTURY; HUMANS; RECEPTORS, ADRENERGIC; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79959708091     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-384921-2.00001-X     Document Type: Book

References (76)

1. Ahlquist R.P. A study of adrenotropic receptors. Am J Physiol 1948, 153:586-600.
2. Allen P.B., Ouimet C.C., Greengard P. Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci USA 1997, 94:9956-9961.
3. Attramadal H., Arriza J.L., Aoki C., Dawson T.M., Codina J., Kwatra M.M., et al. β-arrestin2, a novel member of the arrestin/β-arrestin gene family. J Biol Chem 1992, 267:17882-17890.
4. Aurbach G.D., Fedak S.A., Woodard C.J., Palmer J.S., Hauser D., Troxler F. Beta-adrenergic receptor: Stereospecific interaction of iodinated beta-blocking agent with high affinity site. Science 1974, 186:1223-1224.
5. Barger G., Dale H.H. Chemical structure and sympathomimetic action of amines. J Physiol 1910, 41:19-59.
6. Benovic J.L., Pike L.J., Cerione R.A., Staniszewski C., Yoshimasa T., Codina J., et al. Phosphorylation of the mammalian beta-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein. J Biol Chem 1985, 260:7094-7101.
7. Benovic J.L., Strasser R.H., Caron M.G., Lefkowitz R.J. Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc Natl Acad Sci USA 1986, 83:2797-2801.
8. Benovic J.L., Staniszewski C., Mayor F., Caron M.G., Lefkowitz R.J. Beta-Adrenergic receptor kinase. Activity of partial agonists for stimulation of adenylate cyclase correlates with ability to promote receptor phosphorylation. J Biol Chem 1988, 263:3893-3897.
9. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., et al. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 1994, 46:121-136.
10. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
11. Clark R.B., Kunkel M.W., Friedman J., Goka T.J., Johnson J.A. Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells. Proc Natl Acad Sci USA 1988, 85:1442-1446.
12. Davoren P.R., Sutherland E.W. The effect of L-epinephrine and other agents on the synthesis and release of adenosine 3′,5′-phosphate by whole pigeon erythrocytes. J Biol Chem 1963, 238:3009-3015.
13. De Lean A., Stadel J.M., Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 1980, 255:7108-7117.
14. Dewire S.M., Ahn S., Lefkowitz R.J., Shenoy S.K. Beta-arrestins and cell signaling. Annu Rev Physiol 2007, 69:483-510.
15. Dixon R.A., Kobilka B.K., Strader D.J., Benovic J.L., Dohlman H.G., Frielle T., et al. Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 1986, 321:75-79.
16. Fung B.K., Hurley J.B., Stryer L. Flow of information in the light-triggered cyclic nucleotide cascade of vision. Proc Natl Acad Sci USA 1981, 78:152-156.
17. Galandrin S., Oligny-Longpré G., Bonin H., Ogawa K., Galés C., Bouvier M. Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor. Mol Pharmacol 2008, 74:162-172.
18. Gether U., Lin S., Ghanouni P., Ballesteros J.A., Weinstein H., Kobilka B.K. Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor. EMBO J 1997, 16:6737-6747.
19. Ghanouni P., Steenhuis J.J., Farrens D.L., Kobilka B.K. Agonist-induced conformational changes in the G-protein-coupling domain of the β2-adrenergic receptor. Proc Natl Acad Sci USA 2001, 98:5997-6002.
20. Ghanouni P., Gryczynski Z., Steenhuis J.J., Lee T.W., Farrens D.L., Lakowicz J.R., et al. Functionally different agonists induce distinct conformations in the G protein coupling domain of the β2 adrenergic receptor. J Biol Chem 2001, 276:24433-24436.
21. Goodman O.B., Krupnick J.G., Santini F., Gurevich V.V., Penn R.B., Gagnon A.W., et al. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 1996, 383:447-450.
22. Hein L., Kobilka B.K. Adrenergic receptors from molecular structure to in vivo function. Trends Cardiovasc Med 1997, 7:137-145.
23. Hein L., Limbird L.E., Eglen R.M., Kobilka B.K. Gene substitution/knockout to delineate the role of alpha 2- adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines. Ann NY Acad Sci 1999, 881:265-271.
24. Heubel E. Pathogenese und symptome der chronischen Bleivergiftung 1871, Hirschwald, Berlin.
25. Kenakin T. Principles: Receptor theory in pharmacology. Trends Pharmacol Sci 2004, 25:186-192.
26. Kenakin T., Miller L.J. Seven transmembrane receptors as shapeshifting proteins: The impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 2010, 62:265-304.
27. Kobilka B.K., Kobilka T.S., Daniel K., Regan J.W., Caron M.G., Lefkowitz R.J. Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 1988, 240:1310-1316.
28. Kobilka B.K., Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 2007, 28:397-406.
29. Krupnick J.G., Benovic J.L. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 1998, 38:289-319.
30. Kühn H., McDowell J.H., Leser K.H., Bader S. Phosphorylation of rhodopsin as a possible mechanism of adaptation. Biophys Struct Mech 1977, 29:175-180.
31. Kühn H., Hall S.W., Wilden U. Light-induced binding of 48-kDa protein to photoreceptor membranes is highly enhanced by phosphorylation of rhodopsin. FEBS Lett 1984, 176:473-478.
32. Langley J.N. On the contraction of muscle, chiefly in relation to the presence of "receptive" substances. Part IV. The effect of curare and of some other substances on the nicotine response of the sartorius and gastrocnemius muscles of the frog. J. Physiol 1909, 39:235-295.
33. Laporte S.A., Oakley R.H., Zhang J., Holt J.A., Ferguson S.S., Caron M.G., et al. The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci USA 1999, 96:3712-3717.
34. Lefkowitz R.J., Mukherjee C., Coverstone M., Caron M.G. Stereospecific (3H)(-)-alprenolol binding sites, beta-adrenergic receptors and adenylate cyclase. Biochem Biophys Res Commun 1974, 60:703-709.
35. Lefkowitz R.J., Mullikin D., Caron M.G. Regulation of beta-adrenergic receptors by guanyl-5'-yl imidodiphosphate and other purine nucleotides. J Biol Chem 1976, 251:4686-4892.
36. Lefkowitz R.J., Roth J., Pricer W., Pastan I. ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase. Proc Natl Acad Sci USA 1970, 65:745-752.
37. Lefkowitz R.J., Sharp G.W., Haber E. Specific binding of -adrenergic catecholamines to a subcellular fraction from cardiac muscle. J Biol Chem 1973, 248:342-349.
38. Lefkowitz R.J., Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 2005, 308:512-517.
39. Lefkowitz R.J., Sun J.P., Shukla A.K. A crystal clear view of the beta2-adrenergic receptor. Nat. Biotechnol. 2008, 26:189-191.
40. Levitzki A., Atlas D., Steer M.L. The binding characteristics and number of beta-adrenergic receptors on the turkey erythrocyte. Proc Natl Acad Sci USA 1974, 71:2773-2776.
41. Limbird L.E., Lefkowitz R.J. Resolution of beta-adrenergic receptor binding and adenylate cyclase activity by gel exclusion chromatography. J Biol Chem 1977, 252:799-802.
42. Limbird L.E., Lefkowitz R.J. Agonist-induced increase in apparent beta-adrenergic receptor size. Proc Natl Acad Sci USA 1978, 75:228-232.
43. Limbird L.E., Gill D.M., Lefkowitz R.J. Agonist-promoted coupling of the beta-adrenergic receptor with the guanine nucleotide regulatory protein of the adenylate cyclase system. Proc Natl Acad Sci USA 1980, 77:775-779.
44. Lohse M.J., Benovic J.L., Caron M.G., Lefkowitz R.J. Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J Biol Chem 1990, 265:3202-3211.
45. Lu R., Chen Y., Cottingham C., Peng N., Jiao K., Limbird L.E., et al. Enhanced hypotensive, bradycardic, and hypnotic responses to alpha2-adrenergic agonists in spinophilin-null mice are accompanied by increased G protein coupling to the alpha2A-adrenergic receptor. Mol Pharmacol 2010, 78:279-286.
46. Luttrell L.M., Gesty-Palmer D. Beyond desensitization: Physiological relevance of arrestin-dependent signaling. Pharmacol Rev 2010, 62:305-330.
47. MacMillan L.B., Hein L., Smith M.S., Piascik M.T., Limbird L.E. Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 1996, 273:801-803.
48. Maguire M.E., Van Arsdale P.M., Gilman A.G. An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor. Mol Pharmacol 1976, 12:335-339.
49. Marsh L., Herskowitz J. STE2 protein of Saccharomyces kluyveri is a member of the rhodopsin/beta-adrenergic receptor family and is responsible for recognition of the peptide ligand alpha factor. Proc Natl Acad Sci USA 1988, 85:3855-3859.
50. Monod J., Wyman J., Changeux J.P. On the nature of allosteric transitions: A plausible model. J Mol Biol 1965, 12:88-118.
51. Oakley R.H., Laporte S.A., Holt J.A., Caron M.G., Barak L.S. Differential affinities of visual arrestin, β arrestin1, and β arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 2000, 275:17201-17210.
52. Orly J., Schramm M. Coupling of catecholamine receptor from one cell with adenylate cyclase from another cell by cell fusion. Proc Natl Acad Sci USA 1976, 73:4410-4414.
53. Pfister C., Kühn H., Chabre M. Interaction between photoexcited rhodopsin and peripheral enzymes in frog retinal rods. Influence on the postmetarhodopsin II decay and phosphorylation rate of rhodopsin. Eur J Biochem 1983, 136:489-499.
54. Philipp M., Brede M., Hein L. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol 2002, 283:R287-R295.
55. Pitcher J.A., Freedman N.J., Lefkowitz R.J. G protein-coupled receptor kinases. Annu Rev Biochem 1998, 67:653-692.
56. Rajagopal S., Rajagopal K., Lefkowitz R.J. Teaching old receptors new tricks: Biasing seven-transmembrane receptors. Nat Rev Drug Discovery 2010, 5:373-386.
57. Ritter S.L., Hall R.A. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat Rev Mol Cell Biol 2009, 10:819-830.
58. Rodbell M., Birnbaumer L., Pohl S.L., Krans H.M. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. J Biol Chem 1971, 246:1877-1882.
59. Rodbell M., Krans H.M., Pohl S.L., Birnbaumer L. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon. J Biol Chem 1971, 246:1872-1876.
60. Rosenbaum D.M., Cherezov V., Hanson M.A., Rasmussenm S.G., Thian F.S., Kobilka T.S., et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007, 318:1266-1273.
61. Rosenbaum D.M., Zhang C., Lyons J.A., Holl R., Aragao D., Arlow D.H., et al. Structure and function of an irreversible agonist-beta(2) adrenoceptor complex. Nature 2011, 469:236-240.
62. Ross E.M., Gilman A.G. Reconstitution of catecholamine-sensitive adenylate cyclase activity: Interactions of solubilized components with receptor-replete membranes. Proc Natl Acad Sci USA 1977, 74:3715-3719.
63. Samama P., Cotecchia S., Costa T., Lefkowitz R.J. A mutation-induced activated state of the beta2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 1993, 268:4625-4636.
64. Satoh A., Nakanishi H., Obaishi H., Wada M., Takahashi K., Satoh K., et al. Neurabin-II/spinophilin. An actin filament-binding protein with one pdz domain localized at cadherin-based cell-cell adhesion sites. J Biol Chem 1998, 273:3470-3475.
65. Shenoy S.K., Lefkowitz R.J. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 2003, 375:503-515.
66. Shenoy S.K., Drake M.T., Nelson C.D., Houtz D.A., Xiao K., Madabushi S., et al. Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 2006, 281:1261-1273.
67. Starke K., Endo T., Taube H.D. Pre- and postsynaptic components in effect of drugs with alpha adrenoceptor affinity. Nature 1975, 254:440-441.
68. Su Y.F., Harden T.K., Perkins J.P. Isoproterenol-induced desensitization of adenylate cyclase in human astrocytoma. cells Relation of loss of hormonal responsiveness and decrement in beta-adrenergic receptors. J Biol Chem 1979, 254:38-41.
69. Tan C.M., Wilson M.H., MacMillan L.B., Kobilka B.K., Limbird L.E. Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists. Proc Natl Acad Sci USA 2002, 99:12471-12476.
70. Vaidehi N., Kenakin T. The role of conformational ensembles of seven transmembrane receptors in functional selectivity. Curr Opin Pharmacol 2010, 10:775-781.
71. Violin J.D., Lefkowitz R.J. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 2007, 28:416-422.
72. Wang Q., Limbird L.E. Regulation of alpha2AR trafficking and signaling by interacting proteins. Biochem Pharmacol 2007, 73:1135-1145.
73. Wang Q., Zhao J., Brady A.E., Feng J., Allen P.B., Lefkowitz R.J., et al. Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors. Science 2004, 304:1940-1944.
74. Whalen E.J., Rajagopal S., Lefkowitz R.J. Therapeutic potential of β-arrestin- and G protein-biased agonists. Trends Mol Med 2011, 17:126-139.
75. Wisler J.W., DeWire S.M., Whalen E.J., Violin J.D., Drake M.T., Ahn S., et al. A unique mechanism of beta-blocker action: Carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci USA 2007, 42:16657-16662.
76. Yamazaki A., Halliday K.R., George J.S., Nagao S., Kuo C.H., Ailsworth K.S., et al. Homology between light-activated photoreceptor phosphodiesterase and hormone-activated adenylate cyclase systems. Adv Cyclic Nucleotide Protein Phosphorylation Res 1985, 19:113-124.